2Winawer SJ, Fletcher RH, Miller L, Godlee F,Stolar MH, Mulrow CD, Woolf SH, Glick SN,Ganiats TG, Bond JH, Rosen L, Zapka JG, OlsenSJ, Giardiello FM, Sisk JE, Van Antwerp R,Brown-Davis C, Marciniak DA, Mayer RJ. Colorectal cancer screening: clinical guidelines andrationale. Gastroenterology, 1997, 112: 594～642.
3Noshirwani KC, van Stolk RU, Rybicki LA, BeckGJ. Adenoma size and number are predictive ofadenoma recurrence: implications for surveillancecolonoscopy. Gastrointest Endosc, 2000, 51 (4 Pt 1):433 ～437.
4Schoen RE, Gerber LD, Margulies C. The pathologic measurement of polyp size is preferable tothe endoscopic estimate. Gastrointest Endosc, 1997,46: 492～496.
5van Stolk RU, Beck GJ, Baron JA, Haile R, Summers R. Adenoma characteristics at first colonoscopy as predictors of adenoma recurrence andcharacteristics at follow-up. The Polyp Prevention Study Group. Gastroenterology, 1998, 115:13～18.
6Zauber AG, Winawer SJ, Bond JH, Wayne JD,Schaqiro M, Stewart ET. Can surveillance intervals be lengthened following colonoscopic polypectomy? Gastroenterology, 1998, 112: A50.
7van Stolk RU, Beach M, Baron JA, GreenbergER. For the Polyp Prevention Group. Incidence ofcolorectal cancer during colonoscopic surveillance in a four year polyp prevention trial. Gastroenterology, 1998, 114: A697.
8Rex DK, Cutler CS, Lemmel GT, Rahmani EY,Clark DW, Helper DJ, Lehman GA, Mark DG.Colonoscopic miss rates of adenomas determinedby back-to-back colonoscopies. Gastroenterology,1997, 112: 24～28.
9Otchy DP, Ransohoff DF, Wolff BG, Weaver A,Ilstrup D, Carlson H, Rademacher D. Metachronous colon cancer in persons who have had a largeadenomatous polyp. Am J Gastroenterol, 1996, 91:448～454.
10Terpstra OT, van Blankenstein M, Dees J, EilersGA. Abnormal pattern of cell proliferation in theentire colonic mucosa of patients with colon adenoma or cancer. Gastroenterology, 1987, 92: 704～708.
